People · Operator

Fred A. Mermelstein

Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology

1
Companies
1
Filings
$23.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
NextRNA Therapeutics, Inc.BiotechnologySeries B$23.4M$480.8M2022
Operator network

Fred A. Mermelstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Marc A. Cohen · 5 companies · 1 sharedMarc A. CohenCarl A. Novina · 3 companies · 1 sharedCarl A. NovinaElena A. Prokupets · 3 companies · 1 sharedElena A. ProkupetsJulia A. Novina · 3 companies · 1 sharedJulia A. NovinaArthur A. Becker · 2 companies · 1 sharedArthur A. BeckerBarry A. Polisky · 2 companies · 1 sharedBarry A. PoliskyDominique A. Verhelle · 2 companies · 1 sharedDominique A. Verh…Drew A. Dennison · 2 companies · 1 sharedDrew A. DennisonKenneth A. Anderson · 2 companies · 1 sharedKenneth A. Anders…Malcolm A. Salter · 2 companies · 1 sharedMalcolm A. SalterAlain A. Cohen · 1 companies · 1 sharedAlain A. CohenAndrea A. Armstrong · 1 companies · 1 sharedAndrea A. Armstro…Christine A. Henderson · 1 companies · 1 sharedChristine A. Hend…Susan A. Langer · 1 companies · 1 sharedSusan A. LangerNextRNA Therapeutics, Inc. · $23.4M raisedNextRNA Therapeutics,…Fred A. MermelsteinFM
Fred A. Mermelstein Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Fred A. Mermelstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Marc A. Cohen15
Julia A. Novina13
Elena A. Prokupets13
Carl A. Novina13
Barry A. Polisky12
Malcolm A. Salter12
Dominique A. Verhelle12
Drew A. Dennison12
Arthur A. Becker12
Kenneth A. Anderson12
Christine A. Henderson11
Susan A. Langer11
Alain A. Cohen11
Andrea A. Armstrong11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.